Philly.com – W. Douglas Tynan, Ph.D., ABPP
“Once again the increasing use of psychiatric medications for very young children, under the age of 3, has appeared in the news…In the most recent New York Times article, however, the story emphasizes that the use of stronger medications – atypical anti-psychotic drugs such as Risperdal or Seroquel and antidepressants such as Prozac – is increasing nationally. The problem continues to grow despite the Senate hearings, efforts by state social service agencies to control these prescriptions, and news outlet coverage of the issue. There are three major concerns about the use of these medicines, which have never been systematically evaluated in young children:”(more)